FDA awards grants to seven clinical trials for orphan products
Drug Discovery World
OCTOBER 3, 2024
The US Food and Drug Administration (FDA) has announced seven new clinical trial grants awarded under the Orphan Products Grants Program for clinical trials to address the unmet needs of people affected by rare diseases. In total, clinical researchers will receive approximately $17.2 million over the next four years. Newly funded projects: Palvella Therapeutics received $2.6 million to fund a Phase III study of PTX-022 (Sirolimus) for the treatment of microcystic lymphatic malformations.
Let's personalize your content